Published in Nat Rev Urol on March 04, 2014
Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87
Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice. Prostate Int (2014) 1.09
Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy. Med Sci Monit (2014) 1.02
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prev Res (Phila) (2015) 0.83
Genetic variation: effect on prostate cancer. Biochim Biophys Acta (2014) 0.81
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia. Asian J Androl (2015) 0.79
Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist. Basic Clin Androl (2015) 0.79
Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis. World J Surg Oncol (2015) 0.78
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries. Sci Rep (2017) 0.77
Diet-induced alteration of fatty acid synthase in prostate cancer progression. Oncogenesis (2016) 0.77
Prostate cancer incorrectly diagnosed as a rectal tumor: A case report. Oncol Lett (2015) 0.77
Invited commentary: screening and the elusive etiology of prostate cancer. Am J Epidemiol (2015) 0.77
Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study. Int J Clin Oncol (2016) 0.76
Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study. Urology (2015) 0.76
Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression. Cell Biosci (2015) 0.76
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer. South Asian J Cancer (2015) 0.75
The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients. Investig Clin Urol (2016) 0.75
Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation. Oncotarget (2016) 0.75
A histopathological study of prostate lesions in Lagos, Nigeria: A private practice experience. Niger Med J (2016) 0.75
Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases. Endocr Relat Cancer (2016) 0.75
Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer. Oncotarget (2017) 0.75
Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment. Nat Commun (2017) 0.75
Re: Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy-user bias. Cancer Sci (2015) 0.75
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins. Oncotarget (2016) 0.75
Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis. Onco Targets Ther (2017) 0.75
Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival. Sci Rep (2016) 0.75
Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer. J Nutr Metab (2016) 0.75
Constitutive and Inducible Expression of Invasion-related Factors in PC-3 Prostate Cancer Cells. J Cancer Prev (2015) 0.75
Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications. Ther Adv Med Oncol (2017) 0.75
Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer. Medicine (Baltimore) (2017) 0.75
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis. Onco Targets Ther (2017) 0.75
A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers. Oncotarget (2017) 0.75
PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis. J Cancer (2017) 0.75